Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
Clinical trial NCT07379268 · RECRUITING
Trial details
- NCT number
- NCT07379268
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-01
- Primary completion
- 2028-12-31
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.